First- and second-generation antipsychotic medication and cognitive processing in schizophrenia. - Wikidata - wikimedia - TriplyDB

First- and second-generation antipsychotic medication and cognitive processing in schizophrenia.

First- and second-generation antipsychotic medication and cognitive processing in schizophrenia.

http://www.wikidata.org/entity/Q36228233

about

Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies Muscarinic agonists for the treatment of cognition in schizophrenia Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state The evolution of drug development in schizophrenia: past issues and future opportunities.Reduced context effects on retrieval in first-episode schizophrenia Pharmacogenomics: a path to predictive medicine for schizophrenia.Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia Perceptual Category Judgment Deficits are Related to Prefrontal Decision Making Abnormalities in Schizophrenia.Cognitive deficits in recent-onset and chronic schizophrenia.Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: a review.Verbal learning and memory and their associations with brain morphology and illness course in schizophrenia spectrum psychoses.Cognitive inhibitory control and self-reported impulsivity among violent offenders with schizophrenia.

P2860

Q22251051-73BAEAF2-A4C1-479A-805C-B09EA9CA6D4F Q28301970-A465C49C-7D3E-43AA-AFD8-DB73F601036D Q30466264-FE5929DB-8901-42FB-B133-D67C5AE4480B Q30487850-3988A2A7-6644-4DEE-9C4B-8BADABDB9BD3 Q33570541-B552BD19-4D8E-4B19-93EC-21FFFB64CD06 Q36341739-5B5DA797-87A7-40B4-B161-31B8BE2B72C4 Q36471519-64077861-F397-482D-A3D3-4747A66E0110 Q37434081-32D5EEAE-23D3-4748-A6F5-C1ACB3DAD6CD Q37614666-E2E72948-ACB5-40AA-9D8C-19D496DEF821 Q37920918-20213C40-AFF5-43FC-AF3A-789F005019C5 Q38473103-80C52F67-C2AF-46E4-9B5D-DA12535D685A Q51947724-5E565C82-FF26-459E-B905-781120229F26

P2860

First- and second-generation antipsychotic medication and cognitive processing in schizophrenia.

http://www.wikidata.org/entity/Q36228233

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

First- and second-generation a ...... e processing in schizophrenia.

@ast

First- and second-generation a ...... e processing in schizophrenia.

@en

type

label

First- and second-generation a ...... e processing in schizophrenia.

@ast

First- and second-generation a ...... e processing in schizophrenia.

@en

prefLabel

First- and second-generation a ...... e processing in schizophrenia.

@ast

First- and second-generation a ...... e processing in schizophrenia.

@en

P1433

Q36228233-F2444DA4-7432-4A3E-B8A7-604DAD93E304

P1476

Q36228233-1AC311BF-AAE2-4323-8067-E0766E331D23

P2093

Q36228233-6671F933-14A6-4F02-B756-4B709A324DEB

Q36228233-E4628EAF-30EA-4C3D-A1E7-2381ECD2109C

P2860

Q36228233-18626843-4C68-4673-AE6F-9A729EF46DB7

Q36228233-2E4701D4-BCC8-45AB-827F-B3210A6B860D

Q36228233-7B6E1FB7-0C20-4EAC-85A8-B765F91EECD6

Q36228233-88C46865-52F5-4677-9E85-97BA0253B3D3

Q36228233-A0B730C5-1A4C-4DA6-99F1-4F39E98C4EA0

Q36228233-AC82CA9C-D028-4644-9B9D-42E2D1945AC6

Q36228233-AD0B5E77-EA8A-4FAD-ADA8-6AC36EC37932

Q36228233-AFF7C2C6-B466-4994-B49F-BBCD5907BCD9

Q36228233-C4FBC014-2F5A-4AEC-A966-CB3BECA4C86B

Q36228233-CAE4925D-6FC0-4F03-8B48-10A6F0593A99

P2888

Q36228233-0338B015-DFE8-4D09-AF16-BA03D9C1D2FF

P304

Q36228233-93A31A22-3F26-43F3-8BB5-6E5A04402F68

P31

Q36228233-C49558EE-9425-4B02-B314-9B865D6FC27F

P356

Q36228233-58C13FEC-4C28-483B-A79E-7E0F4E3AF941

P407

Q36228233-1C5E7DDF-8DEB-40D4-B719-993D755DA93D

P433

Q36228233-317512D7-0252-4550-8262-5ED5704F45BB

P478

Q36228233-5290F02D-68F2-4297-8BB5-BEEA85CC7C72

P577

Q36228233-1B6E2CBF-570D-4883-A62A-36D3B3650795

P5875

Q36228233-6852E0EC-C941-4E22-8294-4726E0B8DBE2

P698

Q36228233-2473D7A2-F9BF-4AE9-B31E-C8E7918F3174

P921

Q36228233-32FB83A9-447B-4DB9-9B2B-AC06F6D61654

P356

S11920-005-0085-5

P1433

Current Psychiatry Reports

P1476

First- and second-generation a ...... e processing in schizophrenia.

@en

P2093

Terry E Goldberg

http://www.w3.org/2001/XMLSchema#string

Thomas W Weickert

http://www.w3.org/2001/XMLSchema#string

P2860

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Intelligence in schizophrenia: meta-analysis of the research.

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.

Clinical profile of an atypical antipsychotic: risperidone.

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.

Negative v positive schizophrenia. Definition and validation.

P2888

s11920-005-0085-5

P304

304-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11920-005-0085-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7662798

http://www.w3.org/2001/XMLSchema#string

P698

16098285

http://www.w3.org/2001/XMLSchema#string

P921